In this context, low brain MTHF availability due to FRα autoimmunity further inhibits methionine synthase activity, enhancing the shift from the methionine towards the transsulfuration cycle resulting in downregulation of cellular methylation capacity. The gene discussed is MTR; the disease is Autoimmunity.